FDA Drug Application (205075) for RUFINAMIDE by GLENMARK PHARMS LTD

Back to FDA Applications sponsored by GLENMARK PHARMS LTD

Application Number205075
Product Number001
FormTABLET;ORAL
Dosage200MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRUFINAMIDE
Active IngredientRUFINAMIDE



Back to FDA Applications sponsored by GLENMARK PHARMS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.